PTP-41362-73118
1 vaccination
2 coded responses
9 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-08
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-04-08
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Menstruation irregular — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painFree text: Caused early mensural cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-17
Health check-in — day 7, dose 1Feeling: Good · Site: Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, DiarrheaAdult check-in
- 2021-04-24
- 2021-04-29
- 2021-05-21
- 2021-07-08
-
2022-04-08
Survey response — 12 months, dose 1MedDRA: Alopecia, COVID-19, Dyspnoea, Neuropathy peripheral, Office visit, Pre-existing disease, Renal disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Covid, kidney issues, hair loss, random loss of breath. Continued flair up in neuropathy · Healthcare visit (other): New specialist doctors.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Caused early mensural cycle
Release 11 — 12 months, dose 1
Symptoms: Covid, kidney issues, hair loss, random loss of breath. Continued flair up in neuropathy
Healthcare visit (other): New specialist doctors.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Renal disorder | · | · | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release